AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

ArriVent BioPharma Inc. C... (AVBP)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

25.09

0.24 (0.97%)

At close: Jan 15, 2025, 1:30 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY23	FY22	FY21
Net Income	-69.33M	-36.91M	-51.61M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	895.00K	424.00K	66.67K
Other Working Capital	11.22M	-9.95M	-4.23M
Other Non-Cash Items	n/a	-2.38M	42.67M
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	12.60M	-7.15M	-3.94M
Operating Cash Flow	-55.84M	-43.63M	-12.59M
Capital Expenditures	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a
Purchase of Investments	-25.00M	n/a	n/a
Sales Maturities Of Investments	25.00M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-40.00M
Investing Cash Flow	n/a	n/a	-40.00M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	44.92M	169.72M	119.82M
Financial Cash Flow	42.86M	169.72M	89.87M
Net Cash Flow	-12.98M	126.09M	37.28M
Free Cash Flow	-55.84M	-43.63M	-12.59M